Bioquest Corp
Bioquest Corp (BQST): 9 pipeline candidates · ~2 mo cash runway. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
2.4 months
D/E -1.03 · 0% dilution
N/A
9 candidates
N/A
N/A
A transparent, data-derived signal for Bioquest Corpacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$2.0M
Cash
$15K
Quarterly Burn
$19K
Runway
2.4 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (9 candidates)
Frequently asked questions
How many drug candidates are in Bioquest Corp's pipeline?
Bioquest Corp (BQST) has 9 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Bioquest Corp's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Bioquest Corp has approximately 2.4 months of cash runway.
What is Bioquest Corp's market capitalization?
Bioquest Corp's market capitalization is approximately $2.0M.
Who is the CEO of Bioquest Corp?
Mr. Trent T. Daniel is the chief executive officer of Bioquest Corp (BQST).
Get the full picture on Bioquest Corp
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.